Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.

[1]  A. Markham,et al.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. , 1997, Drugs & aging.

[2]  M. Nicholls,et al.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. , 1995, British journal of clinical pharmacology.

[3]  K. Ferdinand,et al.  Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. , 1995, American journal of hypertension.

[4]  A. Farmer,et al.  Within‐patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine , 1994, Journal of hypertension.

[5]  J. Chalmers.  The place of combination therapy in the treatment of hypertension in 1993. , 1993, Clinical and experimental hypertension.

[6]  D J Reda,et al.  Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo , 1993 .

[7]  E. Jones,et al.  Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects. , 1992, American journal of hypertension.

[8]  H. Letzel,et al.  Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial. , 1990, Journal of Hypertension - Supplement.

[9]  J. Clive,et al.  Quality of life as a vital clinical sign. , 1990, Journal of human hypertension.

[10]  S. G. Smith,et al.  Efficacy and safety of lisinopril in older patients with essential hypertension. , 1988, The American journal of medicine.

[11]  J. Chalmers,et al.  Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. , 1986, Australian and New Zealand journal of medicine.

[12]  S. Tretli,et al.  ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION A Comparative Multicentre Study in General Practice in Norway , 1986, The Lancet.

[13]  P. Erne,et al.  Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients. , 1984, The American journal of medicine.

[14]  G. Tamborini,et al.  Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. , 1984, Circulation.

[15]  P. Erne,et al.  Factors influencing the hypotensive effects of calcium antagonists. , 1983, Hypertension.

[16]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[17]  D. Winsemius,et al.  Relative Importance to Elderly Patients of Effectiveness, Adverse Effects, Convenience and Cost of Antihypertensive Medications , 1994, Drugs & aging.

[18]  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) , 1993, Archives of internal medicine.

[19]  J. Chalmers,et al.  Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[20]  J. Ménard,et al.  Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. , 1990, Journal of hypertension.

[21]  N. Markandu,et al.  Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. , 1985, Journal of cardiovascular pharmacology.

[22]  P. Erne,et al.  Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. , 1985, Journal of cardiovascular pharmacology.